DiscoverThe Drug Discovery World PodcastThe unmet critical need for concussion drug therapies
The unmet critical need for concussion drug therapies

The unmet critical need for concussion drug therapies

Update: 2024-10-29
Share

Description

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.   

In this episode, Megan Thomas is in conversation with CEO of Oxeia, Dr Michael  Wyand, where we talk about Oxeia’s work; the unmet critical need for concussion drug therapies; the challenges facing them, including in clinical trials and investment; the potential market for concussion drugs, and more.

You can now, and find The Drug Discovery World Podcast on SpotifyGoogle Play and Apple Podcasts. 

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

The unmet critical need for concussion drug therapies

The unmet critical need for concussion drug therapies